Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

APC and its longtime supporter Medisca have agreed to a five-year deal that includes Medisca’s five-year commitment as a Platinum-level APC Corporate Patron. The deal, valued at $300,000, includes an exclusive license for APC to use the compounding.com domain for its upcoming cBHT media campaign, as well as for any consumer-focused follow-on campaign aimed at elevating pharmacy compounding.

“We’re deeply grateful for this support from our friends at Medisca,” said APC’s CEO, Scott Brunner. “It’s a vote of confidence in the work APC is doing. We look forward to a productive partnership with Medisca as we defend pharmacy compounding and protect patient access to compounded preparations.”